本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Atara Biotherapeutics

8.54
+0.07500.89%
成交量:2.79万
成交额:23.68万
市值:5,803.44万
市盈率:-0.75
高:8.68
开:8.30
低:8.21
收:8.47
数据加载中...
2024/07/17

重要事件披露

Form 8-K - Current report
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/17

重要事件披露

Form 8-K - Current report
2024/06/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/11

重要事件披露

Form 8-K - Current report
2024/06/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/22

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/18

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities